This approach to cancer treatment focuses on specific genetic mutations or proteins that drive the growth and spread of melanoma. For instance, if a melanoma expresses a particular protein known to fuel its proliferation, medications designed to inhibit that specific protein’s activity can be employed. This contrasts with traditional chemotherapy, which affects all rapidly dividing cells, including healthy ones.
The development of these precise treatments has revolutionized the outlook for individuals with advanced melanoma. By selectively targeting cancerous cells, these therapies often lead to improved outcomes, reduced side effects, and enhanced quality of life compared to older, less specific treatments. Historically, advanced melanoma carried a poor prognosis, but these advancements have significantly improved survival rates and offer a greater chance of long-term disease control.
